Real-World Data Show Lecanemab Is Mostly Safe but Flag a Stroke Signal
A combined real-world cohort and FAERS analysis finds lecanemab generally safe in Alzheimer's patients but flags a strong, unlabeled signal ...
A combined real-world cohort and FAERS analysis finds lecanemab generally safe in Alzheimer's patients but flags a strong, unlabeled signal ...
FDA scientists argue that generative AI will transform drug safety surveillance into hybrid human-AI systems rather than fully automating pharmacovigilance, ...
A machine learning analysis of 18 million FDA adverse event reports spanning 2004 to 2024 reveals distinct cardiovascular risk clusters ...
A survey of 188 Saudi community pharmacists finds near-universal dispensing and counselling but low availability of vaccination, screening, and advanced ...
A mixed methods study in Cambodia shows village malaria workers dramatically expanded follow-up of Plasmodium vivax patients, with coverage rising ...
A new review argues that the dense data generated in neonatal intensive care units could close the evidence gap for ...
Researchers at University Medical Centre Utrecht have published a formal response defending their nationwide self-controlled case series finding that COVID-19 ...
A regulator-mandated study using nationwide registry data from Denmark, Sweden and Norway found no increased risk of pancreatic cancer among ...
A pharmacovigilance analysis of nearly five million adverse-event reports finds that liver injury after CAR T-cell therapy is predominantly early ...
A case report describes new-onset psychosis in a 75-year-old woman within a day of her third intravitreal bevacizumab injection, raising ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine